Aurolife Pharma, LLC recalls Allergy (Fexofenadine Hydrochloride) Tablets USP, 180 mg, 30-count bottles, Distributed by: Aurohealth LLC, 2572 Brunsw…
- Recall date
- August 23, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-1872-2019
- FDA classification
- Class II
- Brand / firm
- Aurolife Pharma, LLC
- Sold / distributed
- Nationwide in the USA
Why it was recalled
Failed Impurities/Degradation Specifications
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Allergy (Fexofenadine Hydrochloride) Tablets USP, 180 mg, 30-count bottles, Distributed by: Aurohealth LLC, 2572 Brunswick Pike, Lawrenceville, NJ 08648; NDC 58602-820-09.
Get recall alerts
Free email alert whenever Aurolife Pharma, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Aurolife Pharma, LLC